Concerns about the ALIFE2 trial

Lancet. 2024 Jan 20;403(10423):245-246. doi: 10.1016/S0140-6736(23)02337-1.

Author

Bingwen Eugene Fan¹

Affiliation

¹ Department of Haematology, Tan Tock Seng Hospital, Novena 308433, Singapore; Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: bingwen_eugene_fan@ttsh.com.sg.

PMID: 38245241
DOI: 10.1016/S0140-6736(23)02337-1

No abstract available

Publication types

Letter